C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,054,511 | -32.4% | 1,642,210 | 0.0% | 0.34% | -26.5% |
| Q2 2023 | $4,516,078 | +87471.8% | 1,642,210 | 0.0% | 0.46% | -27.9% |
| Q1 2023 | $5,157 | -46.8% | 1,642,210 | 0.0% | 0.64% | -40.4% |
| Q4 2022 | $9,689 | -99.9% | 1,642,210 | 0.0% | 1.08% | -37.0% |
| Q3 2022 | $14,402,000 | +16.3% | 1,642,210 | 0.0% | 1.72% | +18.4% |
| Q2 2022 | $12,382,000 | -68.9% | 1,642,210 | 0.0% | 1.45% | -62.5% |
| Q1 2022 | $39,840,000 | -24.7% | 1,642,210 | 0.0% | 3.87% | -7.7% |
| Q4 2021 | $52,879,000 | -27.9% | 1,642,210 | +0.0% | 4.19% | -7.9% |
| Q3 2021 | $73,374,000 | +18.1% | 1,642,209 | 0.0% | 4.55% | +11.8% |
| Q2 2021 | $62,141,000 | +2.3% | 1,642,209 | 0.0% | 4.07% | +18.3% |
| Q1 2021 | $60,745,000 | +11.7% | 1,642,209 | 0.0% | 3.44% | +0.7% |
| Q4 2020 | $54,406,000 | – | 1,642,209 | – | 3.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |